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ABSTRACT
Alzheimer’s disease is a specific form of dementia characterized by the
aggregation of Amyloid-β plaques and tau tangles. New research has found that
the formation of these aggregates occurs after dysregulation of respiratory
activity and the production of radical oxygen species. Proteomic data shows that
these changes are also related to unique gene expression patterns. We
investigate the impact of these findings on new therapeutic options via metabolic
flux analysis of sirtuin stress response pathways and respiratory supercomplex
formation. Our results indicate CRISPR Cas-based gene therapy focused on
upregulating stable CIII expression, and protective changes in SIRT1 and AMPK
expression are potential avenues for therapeutics. This work also highlights the
importance of metabolic enzyme activity in maintaining proper respiratory activity.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by the
aggregation of neurofibrillary tangles and amyloid plaques (Cadenas & Davies, 2000;
Grimm, Friedland, & Eckert, 2016). It is unclear if these aggregates cause cognitive
degeneration or if they are a byproduct of other degenerative stimuli (Herrup, 2015).
However, it is becoming increasingly apparent that mitochondrial impairment plays a
significant role in the onset and progression of AD (Cai, Yan, Li, Quazi, & Zhao, 2012).
Current research suggests that the mitochondrial efficiency plays a significant role on
when and if a person develops dementia (Grimm et al., 2016; Mancuso, Orsucci, Siciliano,
& Murri, 2008). With these new findings, researchers are looking into new ways to
understand AD by studying changes in mitochondrial activity. Synthesis of this new
research and older findings have produced two new theories about AD onset. The two
theories are the Inverse Warburg Hypothesis (IW) and the Mitochondrial Cascade
Hypothesis (MC) which explain the relationship between mitochondrial impairment and
characteristic plaque buildup.
Both the IW and MC theories were created to explain late onset AD (LOAD;
Campion et al., 1999). The IW postulates that, prior to degeneration, there is an
unsustainable increase in metabolic demand by neurons to compensate for respiratory
inefficiency. Because neurons do not process glucose directly, they rely on astrocytes to
process glucose into lactate which is then transferred from the astrocytes to the nearby
neurons (Demetrius & Simon, 2013). One dysfunctional neuron’s elevated metabolic
demand consumes a high concentration of the astrocyte’s limited glucose pool. The high
consumption leaves nearby, healthy neurons lacking essential metabolites. Eventually the
entire neuronal system begins collapsing leading to apoptosis and memory loss (Grimm
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et al., 2016). There is no recorded evidence of the initial increase in metabolic demand
that the IW theory predicts making it difficult to prove.
The MC hypothesis claims that genetics determine an innate level of respiratory
chain efficiency. As people age, respiratory activity slows producing less ATP and more
H2O2. During this process, minor impairments in the respiratory chain become more
apparent. The subsequently high levels of ROS leave the mitochondria more susceptible
to oxidative damage (Mosconi, 2013; Swerdlow, Burns, & Khan, 2010). ROS accumulation
leads to activation of transcription factors peroxisome proliferator-activates receptor
gamma, coactivator 1 (PGC1α) and forkhead box O3 (FOXO3) to increase mitochondrial
biogenesis or induce autophagic pathways (Brenmoehl & Hoeflich, 2013). Proteomic data
showing differences in gene expression support this theory. Compared to control tissue,
nuclear encoded mitochondrial subunit expression is suppressed, and cell death related
pathways are upregulated.
We have created two models to investigate how changes in respiratory activity
explained by these hypotheses influence mitochondrial viability as well as changes in
stress signaling. Based on proteomic data, we investigated the impact changes in nuclear
encoded subunits play in respiratory efficiency as well as how the related ROS production
can influence gene transcription. During this investigation, we hope to better understand
how the mitochondria reduces and responds to long term increases in oxidative stress as
well as how to leverage these pathways to treat a serious underlying problem in AD
affected brain cells.

Respiratory Modeling
Respiration is the process of oxidizing NADH and FADH2 to release electrons
which reduce Coenzyme Q (CoQ) before being transferred to cytochrome C (cyt C) and
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eventually convert O2 gas into water. This process is carried out across multiple respiratory
complexes (RC), which pump high concentration of protons from the matrix into the
intermembrane space (Murphy, 2009). A few decades ago, this was believed to occur
across individual complexes embedded in the inner membrane. Today, two different
models, fluid and solid state, have been proposed to describe how this transfer takes
place. The fluid model which describes the electron transport chain (ETC) as separate
complexes within the membrane. Once loaded or unloaded, CoQ and Cyt c diffuse until
they reach the next complex in the RC (Letts, Fiedorczuk, & Sazanov, 2016). The solid
state model proposes that individual complexes assemble to form a large multimeric
complex known as the respirasome to be functional (Lapuente-Brun et al., 2013). In reality,
the mitochondria functions with a spectrum of individual complexes, supercomplexes
(SCs; functional intermediaries composed of a fraction of the complexes within the
respirasome) and the respirasome. The purpose of these structures is unclear. SCs may
reduce the diffusion distance of Cyt c and CoQ which may increase RC efficiency
(Milenkovic, Blaza, Larsson, & Hirst, 2017). Researchers have found that formation of the
respirasome limits ROS production by stabilizing NADH dehydrogenase (CI) structure and
covering one oxygen binding site on CI which plays a role in mitochondrial stress signaling
(Stroud et al., 2016). SC assembly varies with cell state and type, which indicates SC
formation could be physiologically significant and needs further exploration (Lopez-Fabuel
et al., 2016).
CI is the largest of the respiratory chain complexes, it oxidizes NADH and transfers
the electrons to CoQ. This predominant producer of signaling-linked ROS contains two
oxygen binding sites, one of which is protected when CI assembles to form the
respirasome and other SCs. The two O2 binding sites are Flavin mononucleotide (FMN)
and N2 (an iron-sulfur cluster); oxygen binding at either location results in ROS production
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(Acín-Pérez, Fernández-Silva, Peleato, Pérez-Martos, & Enriquez, 2008). Reverse
electron transport (RET), which inefficiently reduces NAD when the Q pool is highly
reduced and results in heightened levels of mitochondrial ROS (Lambert & Brand, 2004).
RET occurs when CI, CoQ and later complexes become saturated with electrons. This
ROS production seems to be linked to CI in its monomeric form, not as part of a complex
with CIII or within the respirasome (Lenaz et al., 2010). Arthur, Morton, Dunham, Keeney,
and Bennett (2009) found that the connection may in part be due to a slowed electron flow
though CI and higher stability when part of an SC.
If CI is not properly stabilized, increasing concentrations of ROS are produced
causing mitochondrial oxidative stress (Cadenas & Davies, 2000; Liu et al., 2010; Ray,
Huang, & Tsuji, 2012). This oxidative stress can activate signaling cascades which change
gene transcription (Bechtel & Bauer, 2009). Changes in gene transcription can be seen
by analyzing the changes in an organism’s proteome. Our collaborators with Dr. Castora
at Eastern Virginia Medical School have done analyses that show changes in
mitochondrial biogenesis with AD. Their analysis of tissues affected by AD indicate that
the pathways related to the changes in ROS proliferation, defense, and energy production
are altered. Our proposed mitochondrial models (SC assembly and oxidative stress) focus
on the effects of oxidative stress on the antioxidant defense system and the induction of
stress response signaling cascades. Through careful analysis we propose for effective
therapy routes, SIRT1, AMPK and ETC subunit UQCRC1, for in vitro AD treatment testing.
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Supercomplex assembly model
After individual complexes have formed, complexes CI, Ubiquinone-Cytochrome
C Reductase (CIII), and Cytochrome C Oxidase (CIV) begin to associate and form SCs.
SCs are stable intermediates between respirasomes (solid state model) and individual
complexes (fluid model). The two most prevalent SC compositions are CIVCIII2 and CICIII2
(abbreviated CIVCIII and CICIII), the latter being more common (Ramírez-Camacho,
Flores-Herrera, & Zazueta, 2019). The work by Maranzana et al. (2013), has implicated
SCs in increasing respiratory efficiency and reducing ROS proliferation. SC and
Figure 1A & B:
The two pathways
for respirasome
formation involve
two SC
intermediates,
CICIII and CIVCIII
A: CICIII forms
and assembles
with CIV
containing the
COX7A2 subunit.
B: CIVCIII forms
using CIV with the
COX7A2L subunit
then with CI to
form the final
respirasome.

A

B

respirasome concentrations also vary between cell types. For example, astrocytes have
been shown to have lower levels of SC formation, and this increases the basal level of
ROS within the mitochondria (Lopez-Fabuel et al., 2016).
Nuclear encoded ETC subunits are used to stabilize complexes as well as
assemble SCs and respirasomes. The lesser found SC CIVCIII formation requires the
COX7A2L isoform being present in CIV; it results in rapid assembly of the respirasome
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(Lobo-Jarne et al., 2018; Figure 1b).COX7A2, the shorter isoform, within CIV leads to
CICIII SC intermediate formation before final respirasome formation (Lapuente-Brun et
al., 2013; Figure 1a). Within CIII, the expression of subunits, UQCRFS1, UQCRC1 and
UQCRB ensure stable association with COX7A2L (Letts et al., 2016). CI association with
the CIII dimer (usually forming CICIII2) reduces ROS formation in the mitochondria making
the association highly favorable both in vivo and in vitro (Greggio et al., 2017). This
association utilizes two bonding groups for stabilization including CI subunits NDUFB4

Figure 2: Assembly of SC’s. is dependent on the expression of nuclear encoded
subunits NDUFB9, NDUFA11, NDUFB4, NDUFS1 in CI and UQCRFS1,
UQCRC1, and UQCRQ in CIII

and NDUFB9 which bind to CIII subunits UQCRFS1 and UQCRC1. CICIII also uses
NDUFA11 and NDUFB4 to bond with UQCRQ (Letts et al., 2016; Stroud et al., 2016).
Absence of one of these subunits does not prevent SC formation, but it does form a less
stable association between individual complexes (Acin-Perez & Enriquez, 2014).
An SC with a CICIII2CIV composition is known as a respirasome, but larger
respirasome structures have been reported with up to four CIII and CIV present (Letts et
al., 2016). Only 20% of mitochondrial CIV is incorporated into the respirasome compared
to 55-65% of CIII and over 85% of CI (Greggio et al., 2017).This near complete
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incorporation of CI into SCs supports the hypothesis that all SC formation stabilizes CI
and reduces ROS production (Maranzana et al., 2013). Lopez-Fabuel et al. (2016) report
that CI subunit NDUFS1 deletion or downregulation has been shown to inhibit respirasome
formation. This loss in vivo could significantly affect mitochondrial SC composition which
in turn can change ROS production and mitochondrial signaling.

Oxidative Stress Modeling

Figure 3: The innate antioxidant system contains three enzymes SOD2, Cat
and Gpx which process superoxide through a series of reaction to form inert
water and oxygen gas.

Occasionally electrons escape ETC complexes during electron transport and
create hydroxyl and superoxide radicals (Figure 3; Murphy, 2009; Sena & Chandel, 2012).
Small amounts of ROS production is normal and easily regulated by constitutively
expressed antioxidant proteins including superoxide dismutase (SOD2), Glutathione
peroxidase (Gpx), Catalase (Cat) (Ighodaro & Akinloye, 2017). These proteins convert
ROS into inert water or signaling molecules such as hydrogen peroxide. This is typical
mitochondrial activity, but when more ROS is being produced than these antioxidant
proteins can handle, oxidative stress signaling activates changes in gene expression to
stop ROS accumulation or eliminate dysfunctional mitochondria (Ogura et al., 2018).
PGC1α and FOXO3 are two important transcription factors that mitigate oxidative stress.
They lead to the induction of antioxidant and autophagic proteins to include mitophagy
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which help eliminate terminally dysfunctional mitochondria and prevent cell apoptosis
(Blacker & Duchen, 2016). Mitochondrial biogenesis is also altered by these changes in
gene transcription which increase ETC subunit and antioxidant transcription. If these
interventions fail, apoptosis is induced to prevent total cell dysfunction and cellular decay
(Du & Yan, 2010).
During the process of activating antioxidant systems, autophagy and apoptosis,
pathological biomarkers of AD including amyloid aggregates and hyper phosphorylated
tau are produced and accumulate, which amplifies these initial changes in gene
transcription (Kim, Kim, Rhie, & Yoon, 2015). Based on the mitochondrial cascade
hypothesis and the work done by Dr. Castora’s research group, we propose that gene
therapies focused on reestablishing basal mitochondrial function, increasing ATP
(adenosine triphosphate) and decreasing ROS production, we can successfully minimize
or halt the accumulation of aggregates.

Pathways
Radical Quenching
The ETC oxidizes NADH and FADH2 to create the membrane potential for
oxidative phosphorylation. During this process, electrons can leak out of the ETC and
create ROS (Starkov & Fiskum, 2003). To combat the production of excess ROS, the cell
has evolved an antioxidant system involving two lines of defense; initial radical quenching
and subsequent alterations in gene transcription (Ighodaro & Akinloye, 2017; Zhang et al.,
2018). Sirtuins (SIRTs) are a family of proteins predominately found within the cytosol,
nucleus, and mitochondria. The two primary SIRTs found in the human brain are SIRT3
and SIRT1 (Brenmoehl & Hoeflich, 2013). SIRT1 and SIRT3 use NAD to modulate the
activation of local enzymes (Figure 4). When NADH levels are low and therefore NAD
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levels are high, the cell can enter into an energy deprived or stressed state (Stein & Imai,
2012). This causes an increase in NAD which increases SIRT activity making SIRTs
valuable nutrient sensors. Their increased activity modulates enzyme activation via
deacetylation to regulate enzyme activity in response to the cellular and mitochondrial
NAD/NADH ratios (Brenmoehl & Hoeflich, 2013; Feldman, Dittenhafer-Reed, & Denu,
2012). SIRT3 regulates the activity of antioxidant enzymes as well as the ETC and ATP
synthase in the mitochondria (Kincaid & Bossy-Wetzel, 2013; Rangarajan, Karthikeyan,
Lu, Ling, & Dheen, 2015). Metabolic activity in the nucleus and cytoplasm is modulated
by SIRT1 (Cantó et al., 2009). When active, SIRT1 can activate multiple pathways related
to antioxidant defense, cell metabolism, mitophagy and apoptosis (Feldman et al., 2012).
The mitochondria keep an NAD/NADH ratio around 0-10 under normal conditions,
allowing for low levels of SIRT3’s antioxidant activities and promoting cell longevity
(Kincaid & Bossy-Wetzel, 2013). Deacetylation uses NAD which is converted into the
sirtuin inhibiting molecule, NAM (nicotinamide; Guan, Lin, Knoll, & Chakrabarti, 2014). To
permit continued SIRT activity, NAM must be converted back to NAD. This is done by two
enzymes, NAMPT (nicotinamide phosphoribosyltransferase) and NMNPT (nicotinamide

Figure 4: General SIRT1 and SIRT3 deacetylation mechanism. NAD is a cofactor and
the enzymatic reaction produces inhibitor NAM which must then be converted back to
NAD by NAMPT and NMNT. The rate limiting step in this regenerative cycle is the
conversion of NMN to NAD (as shown by the thinner arrow).
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mononucleotide adenylyltransferase; Figure 4). NAMPT is the rate limiting step in this
reaction chain (Ling Liu et al., 2018). Slowing of NAMPT’s activity increases the NAM pool
(Nikiforov, Dölle, Niere, & Ziegler, 2011).
Radical quenching is performed by the antioxidant enzyme system which includes
SOD2, Cat, and Gpx (Ighodaro & Akinloye, 2017). Cat and SOD2 have low levels of
activity under normal conditions, but SIRT3 increases their activity as ROS accumulates
in the matrix (Chen et al., 2011; Rangarajan et al., 2015). This allows the mitochondria to
conserve their energy and only induce energy demanding changes in gene expression
under periods of stress. SOD2 converts radical oxygen into peroxide (Sun, Oberley, & Li,
1988). Gpx uses two monomers of glutathione (GSH) to convert peroxide into water
creating a glutathione dimer (GSSG) in the process. GSSG is then reduced to GSH by
glutathione reductase (GR) so that Gpx can continue processing the peroxide being
produced by SOD2 (Carlberg & Mannervik, 1975; Ighodaro & Akinloye, 2017). When there
is a high concentration of glutathione dimers, common under oxidative stress conditions,
SIRT3 deacetylates IDH2, catalyzing the reduction of glutathione dimers back to their
monomeric state. (Yu, Dittenhafer-Reed, & Denu, 2012). If peroxide levels get too high,
Cat will begin to convert the excess peroxide into water and oxygen (Bechtel & Bauer,
2009).
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Response Pathways

Figure 5: Activation of
AMPK requires both a
phosphatase and AMP.
Once activated, AMPK can
phosphorylate
many
different proteins related to
metabolism and oxidative
stress regulation.

Figure 6: Deacetylation of LKB1 results in AMPK activation under energy deficient
conditions (high AMP). Activation of AMPK results in transcription factor activation
and changes in metabolic activity increasing in NAD/NADH ratio and SIRT1 activity.

Activation of AMP-activated protein kinase (AMPK) is the transition point from
quick modifications of enzyme activity to changes in gene transcription to implement new
stress response strategies (Figure 5) (Mihaylova & Shaw, 2011). AMPK activation is
dependent on the AMP/ATP ratio, making it an energy sensor. The binding of AMP to
AMPK results in increased activity of AMPK. Activation at high AMP/ATP ratios leads to
the induction of PGC1α, FOXO3, and metabolic changes (Figure 6; Hart et al., 2015).
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As ROS accumulate in the mitochondria, oxidative damage to the lipid bilayer,
proteins and mtDNA will cause cellular stress and dysfunction. If there continues to be an
increase in ROS production beyond the capacity of the antioxidant system, mitophagy will
be activated and the mitochondria degraded (Mihaylova & Shaw, 2011). When the majority
of mitochondria within a cell are dysfunctional, cell death can be initiated to prevent
excessive consumption of valuable resources and deleterious signaling from hurting
neighboring cells (Lukiw, 2004). This clearance requires changes in gene transcription.
For this reason, one of the other targets of SIRT3 is the promoter FOXO3a. SIRT3
deacetylates the protein allowing its export from the mitochondria to the cytosol and further
posttranslational modifications which result in changes in mitochondrial gene transcription
(Rangarajan et al., 2015).
A

B

Figure 7A & B: Transcription Factor Activation A. PGC1a activation increases
antioxidant transcription and mitochondrial biogenesis. B. FOXO3a activation
leads to mitochondrial degradation as well as increased antioxidant expression.

Before FOXO3a can be activated by AMPK, it must first be deacetylated by SIRT3
in the mitochondria (permitting export to the cytosol), and SIRT1 in the cytosol.
Phosphorylation allows for translocation to the nucleus and activation of different
transcription factors. PGC1α is activated by initial deacetylation by SIRT1 in the nucleus
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and subsequent phosphorylation by AMPK (Figure 7; Brenmoehl & Hoeflich, 2013; Zrelli,
Matsuoka, Kitazaki, Zarrouk, & Miyazaki, 2011). In the nucleus, SIRT1 activates LKB1 via
deacetylation. LKB1 can then activate AMPK (Zhang et al., 2018; Figure 6). These
pathways are key to the initial response to changes in available glucose, energy and
response to metabolic stress and ROS. In turn, these enzymes are regulated by ROS and
cofactor levels within the brain. Once activated, FOXO3a will promote the transcription of
SOD2, Cat, and different autophagic pathways (Cantó et al., 2009; Hart et al., 2015).
Activation of the PGC1α promoter leads to increased antioxidant and biogenesis enzyme
transcription (Figure 7; Sheng et al., 2012). Its gene targets include: SIRT3, PGC1α, Nrf1 and nuclear respiratory factors (Nrf-1 and Nrf-2) that lead to changes in ETC and ATP
synthase gene expression (Ruetenik & Barrientos, 2015).

Methods
These models were created in CellDesigner 4.2 and converted into a set of
ordinary differential equations by SBMLsqueezer (Dräger, Hassis, Supper, Schröder, &
Zell, 2008a; Xie, Allaire, & Grolemund, 2019). Model analysis was done in COPASI
4.24.197 (Hoops et al., 2006). Every arrow within the model is represented by a “flux
equation.” If the arrow represents formation of the specie, the flux value is positive (Figure
8). If the reaction is using the specie, the reaction with have a negative value. These
equations can describe catalyzed and uncatalyzed reactions. If the reaction is not enzyme
catalyzed, the flux is described by a simple mass action equation (Equation 1). Like
Michaelis-Menten (M-M), the mass action equation also has a rate constant (kcat) but
unlike M-M, the overall rate is strictly dependent on the concentration of substrate present.
If the reaction is enzyme catalyzed, then the equation takes the form of an M-M equation
(2). M-M describes the rate of an enzymatic reaction using two constants. The first
describes and enzyme’s binding affinity for its substrate(s), the M-M constant (Km). The
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second describes the maximum rate of the reaction (kcat) (Equation 2). For reactions with
more than one substrate, the M-M equation is modified to accommodate a second
substrate assuming a random order mechanism (Equation 3). This equation has an
additional Km specific for the second substrate and an inhibition constant (Ki). Like M-M,
bi-substrate random order mechanisms assume rapid equilibrium. Under these conditions,
𝐾𝑖2 𝐾𝑚1 = 𝐾𝑖1 𝐾𝑚2 and the latter is simplified out of the final equation (Dräger, Hassis,
Supper, Schröder, & Zell, 2008b). These equations are combined to form a series of Flux
equations that describe the entire reaction (Figure 8).

𝑘𝑐𝑎𝑡 ∗ [𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒]

(1)

𝑘𝑐𝑎𝑡 ∗[𝑒𝑛𝑧𝑦𝑚𝑒]∗[𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒]
[𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒]+𝐾𝑚

(2)

𝑘𝑐𝑎𝑡 ∗[𝑒𝑛𝑧𝑦𝑚𝑒]∗[𝑠1]∗[𝑠2]
𝐾𝑖2 ∗𝐾𝑚1 +[𝑠1]∗[𝑠2]+𝐾𝑚1 +𝐾𝑚2

(3)

Figure 8: Flux equations describing the cleavage of APP protein to AB42. Each
specie (APP, C99, and AB42) have a differential equation describing the change in
concentration over time. Positive equations calculate the production of a specie,
negative equations calculate the consumption of a protein.

Concentrations (uM) of proteins were calculated using brain tissue specific
abundances from the Pax database and the molecular weights from the Uniprot database
(The Uniprot Consortium, 2019; Wang, Herrmann, Simonovic, Szklarczyk, & von Mering,
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2015). Metabolite concentrations were taken from the Human Metabolome Database
(Wishart et al., 2018). Parameter values were assigned from the BRENDA database
(Placzek et al., 2017).

Model Assumptions
SC Assembly
SC assembly is a complex, reactive process of combining respiratory complexes
into larger structures. As Late-Onset Alzheimer’s Disease is a slow degenerative disease,
we followed the MC hypothesis that predicts small differences in RC subunit expression
cause a change in respiratory efficiency which can leave neurons more susceptible to
inflammation, oxidative damage, and cell death. The SC assembly model investigates how
changes in gene expression, determined through proteomic analysis, influence SC
assembly and sequestration of CI to reduce ROS formation. The initial model (Figure S1)
considers the interactions between four CI subunits and five CIII nuclear encoded subunits
not required for ETC function, but required to stabilize the complexes. The stability of the
respirasome depends on the expression of associating subunits within each respiratory
complex (Lenaz et al., 2010; Ramírez-Camacho et al., 2019). Figure S1 shows that the
expression of different subunits, or the loss of subunits, produces respiratory complexes
with differing levels of SC stability. Weaker connections cause an increase in ROS
production as CI will not be fully stabilized by the SC formation (parameters and equations
can be found in the supplement, S3 and S2). When the concentrations of subunits are
considered (Table 1), and assuming preference for creating complexes with all of the
subunits, S1 is reduced to the model shown in Figure 9.
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Figure 9: Based on cellular subunit concentrations, the model was reduces to
a combination of six complex types that could assemble to form one of three
SCs and complete respirasome.

The high concentration of NDUFS1 predicts that assembly favors respirasome
formation. Missing one or two subunits results in a weaker association (s2CICIII). When
the complexes contain all of the stabilizing subunits, the SC is less likely to disassemble
and forms a complete respirasome at a faster rate. The availability of predominant CIV
COX7 isoforms COX7A2 and COX7A2L determines whether SC CICIII or CIVCIII will form
(Lobo-Jarne et al., 2018).
Antioxidant Model
In living cells, the NAD/NADH pools are linked through the reduction and oxidation
of various metabolites to connect glycolysis in the cytosol to energy production in the
mitochondria. These two separate pools have differing NAD/NADH ratios to facilitate
normal compartment activity, energy production within the mitochondria, and cofactors in
the cytosol. AMPK also regulates the NAD/NADH ratio in the cytosol, as it does in vivo
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Figure 10: The mitochondria model being simulated to test analyze the activation of
transcription factors and antioxidant system capacity.

(Cantó et al., 2009). In this model, we assumed that the two pools were separate and that
the local changes in the NAD/NADH ratios are only changing in response to respiratory
activity, ROS production and AMPK-mediated metabolic changes. ATP consumption was
also generalized to hydrolysis of ATP to AMP rather than ADP. Though both do happen,
the simplification to only show ATP and AMP levels was done to show ATP consumption
as well as activation of AMPK through AMP binding The ETC concentration is also
assumed due to stable complexes not missing subunits.

Parameter Optimization
The final parameter set for the oxidative stress models was found by providing an
initial parameter set. This set was created based on rate constants found in the BRENDA
database. Those that could not be found were given an initial value of 0.01 for Km and 1
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for kcat. The initial and final parameter sets can be found in the supplement (S7 and S6).
Parameter units for kcat, and Km are min-1 and uM respectively. This set underwent an
optimization using the Hooke and Jeeves solver in COPASI to produce the final parameter
set. These adjusted values better illustrate true pathway activity.

Sensitivity data
A sensitivity analysis (SA) of the oxidative stress model was performed to quantify
sensitive points within the model system. The task perturbs one specie concentration by
1%, and COPASI records how this change effects the dependent variables of the system
(reaction rates and transient concentrations). The results are presented as the average
percent dependency of a dependent variable’s value on the initial concentration being
varied. This analysis is only accurate for perturbations up to 5%, higher changes in
concentration deviate from the predicted trend.

Treatment Tests
Treatment data was determined using COPASI’s time course analysis. Each
treatment mimics the effects of CRISPR-Cas type gene therapy and was done by
adjusting the protein concentration up or down 50%. Steps of 0.1 minutes were used to
record transient concentration values over the course of a 100 minute simulations. Most
data is presented as the percent difference between the control model and the treatment
model. Calculations and graphing were done in RStudio (3.5.2) by finding the difference
between treatment (up or down regulation) groups and the control then dividing by the
control concentration and multiplying by 100.

Results
The two models produced data explaining different aspects of mitochondrial
dysfunction and potential treatment directions. The SC assembly model demonstrates
how differences in AD and healthy gene expression can change the concentration of SC‘s
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and respirasomes in the cells which has wider impacts on mitochondrial efficiency. The
oxidative stress model shows that an increase in ROS due to structural or other changes
in SC content and formation observed in the SC assembly model can impact the activation
of transcription factors. Together these therapeutic tests provide valuable information on
how changes in subunit or enzyme expression can influence further changes in gene
transcription in response to superoxide production.

SC Assembly Results
The formation of SC’s varies between cell types and is implicated in ROS
production (Acin-Perez & Enriquez, 2014). The uniqueness of SC formation to cell types
predicts that changes in assembly will have widespread effects on mitochondrial and
subsequently cellular homeostasis. To understand how AD affects respirasome formation
and to grow intuition about how increasing subunit expression can either alleviate or
exacerbate these issues, we simulated SC formation in control and AD conditions. After
compiling specie concentrations, the fold regulations from Dr. Castora’s work was used to
determine the AD concentrations (Table 1). The values were then loaded into the model
assuming that only one subunit could be absent from a functional complex. There is an
overall decrease in available subunits including a decrease of approximately 2-fold in
essential respirasome assembly subunit NDUFS1.
After determining AD ETC concentrations, treatment sets were created by
increasing one subunit concentration by 50% relative to AD concentrations. The
concentration of individual complexes was reassessed with the treatment and shown in
Table 2. The treatment sets were analyzed for how they affected CI stability via assembly
with CIII and CIV. CIII is an important initial CI binding partner with CIV providing minor
additional stability after CICIII formation (Lobo-Jarne et al., 2018). Subunit targets were
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1 (uM)

Control AD

UQCRFS1
UQCRC1
UQCRQ
NDUFB9
NDUFB4
NDUFA11
NDUFS1
COX7A2L
COX7A2

13.62
9.57
5.14
7.42
10.06
1.85
6.29
3.54
28.63
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7.41
3.75
2.49
2.52
9.22
0.84
2.44
2.04
13.39

Table 1: Control and AD tissue ETC subunit concentrations given
in uM. Complex abbreviations: UQCR- CIII, NDUF- CI, COX- CIV

2 (uM)

Control

AD

UQCRC1

UQCRQ

NDUFA11

NDUFS1

NDUFB9

CI
B9B4A11S1

1.85

0.84

0.84

0.84

1.26

0.84

0.84

B9B4S1

4.44

1.60

1.60

1.60

1.18

2.83

2.93

FS1QC1

5.15

2.49

2.49

3.73

2.49

2.49

2.49

FS1C1

2.72

1.26

3.13

0.02

1.26

1.26

1.26

CIII

Table 2: Initial concentrations of individual complexes based on control, AD and treatment
subunit concentrations. Treatment sets were created by increasing one subunits
concentration by 50%. Subunits that did not increase or decrease the concentration of
complexes were not considered

selected based on their effect on CI or CIII concentrations compared to AD values.
Simulations of SC assembly produced information about changes in respirasome
concentration (Figure 11) and changes in the percent of CI: free CI, and sequestered by
CICIII or respirasomes (Figure 12). The percentage of free CI in the AD sample is double
that of the control, and the decreased respirasome formation (Figure 11 & 12) indicates
that the AD tissue underwent a long period of oxidative stress. The CI subunit treatments
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11

Figure 11: Respirasome concentration (uM) in the control, AD, and treatment
groups
122

Figure 12: Percent of CI assembled into SCs (blue) respirasomes (green) or free
(red) in control and treatment groups.

predict that increasing respirasome concentration comes with an increase in free CI and
potentially dangerous levels of ROS production. NDUFS1 and NDUFB9 treatments were
able to increase the concentration of respirasome (Figure 12), but this increase in
respirasome concentration was paralleled by an increase in free CI. UQCRC1 treatment
was the only therapy predicted to increase respirasome formation and CI sequestration
and ultimately a decreased percentage of free CI. Based on this model, we predict that
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targeting increased CIII binding to CI and not increasing available CI for respirasome
binding is a viable treatment strategy to increase sequestration of CI and reduce ROS
production related to CI activity.

Oxidative Stress Model Results
3

ETC

Metabolic SIRT3

ATPsyn

Concentration Sensitivity
NADH

-3.408 3.428

0.000

0

O2 Radicals

0.003

0.000

0

NADPH

-0.013 -2.142

0.000

0

Glutathione Dimer

0.003

0.996

0.000

0

Exported FOXO3

0.000

0.004

0.078

0

Peroxide Formation

0.003

0.990

0.000

0

e- capture

1.002

0.982

-0.016 0

GSSG reduction

0.003

0.990

0.000

0

FOXO3 export

0.000

0.006

0.130

0

0.563

Flux Sensitivity

Table 3: Scaled SA analysis of the oxidative stress model to perturbations in therapy
target species ETC, Metabolic Enzymes, SIRT3, and ATP synthase. Upper: sensitivity
of key model species concentrations. Lower: Sensitivity of reaction fluxes to
perturbations

Mitochondrial biogenesis is a delicate process facilitating mitochondrial activity
through increased antioxidant and mitochondrial subunit expression in response to
changes in ATP and ROS production. When energy production cannot be salvaged and
continual oxidative stress places the cell at risk of apoptosis, these response pathways
activate autophagy and mitophagy. Our results predict that metabolic activity, ETC stability
and electron saturation play important roles in ROS generation and mitochondrial
oxidative stress. SIRT1 and AMPK are also an important for sending extra-mitochondrial
stress signals which activate and transport transcription factors.
An SA of the oxidative stress model was done to assess potential therapeutic
targets. The analysis predicted that increased stable ETC, changes in metabolic enzymes

Modeling the effects of SC formation and stress response on AD progression

23

and increased SIRT3 protein will decrease superoxide accumulation or activate the
oxidative stress response. It also predicts that treatments dealing with ETC and metabolic
enzyme concentrations will have opposing effects (Table 3). Increased metabolic activity
meant that NADH levels increased, providing more substrate for energy production.
However, as the literature also shows (Pryde & Hirst, 2011), increased availability of
NADH is linked to heightened superoxide levels as the ETC and CoQ pools become more
reduced. The high levels of reduced ETC and CoQ lead to reverse electron transport and
an increased potential for oxygen binding to CI. Both of these facilitate superoxide
production. An increase in NADH can also dampen the ability of SIRT3 to increase
antioxidant activity and activate FOXO3 export from the mitochondria. Decreased levels
of NADPH and increasing glutathione dimers also indicate that changes in the metabolic
activity affect the overall redox state of the mitochondria (Table 3). The minimal change in
GSSG reduction and increased FOXO3 export indicate a higher level of stress and
subsequent activation of a stress response. Low changes in superoxide with increased
stable ETC is in agreement with the literature (Ramírez-Camacho et al., 2019) that CI
saturation with electrons (from NADH) leads to increased superoxide production. Higher
levels of stable ETC complexes results in a lower percentage of these complexes existing
in a reduced state. This limits the potential production of superoxide. Within the model,
increasing the ETC did not change peroxide production (a common marker of superoxide
production) compared to the control. As small amounts of peroxide production are
important for normal mitochondrial signaling, if the SA results hold true at perturbations at
higher than 1% this provides a promising avenue for targeting SC stability for AD
treatment.
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The SA indicated that metabolic enzymes had a negative effect on the model.
Therefore, when considering treatments, we tested a 50% decrease in metabolic
enzymes, as well as a 50% increase in SIRT3 and stable ETC. After an initial spike in
activity related to beginning the model simulation, there is no change in superoxide
production by the ETC while the metabolic enzyme treatment decreased superoxide
production (Figure 13). As a certain level of peroxide is necessary for normal cell function,
the benefits of metabolic enzyme treatment are likely highly sensitive to the exact enzymes
and pathways being targeted.

13

Figure 13: Percent difference in superoxide production compared to control.
Therapy targets ETC and SIRT3 do not make a long term impact on the production
of superoxide. Theoretical metabolic enzyme therapy reduces the superoxide
production by approximately 50%
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14

Figure 14: Percent change in NADP+ concentration with ETC, metabolic
enzyme and SIRT3 treatment compared to control.
15

The decreasing NADP+ concentration with metabolic treatment (Figure 14)
demonstrates that the antioxidant cofactor is becoming more reduced with treatment and
the mitochondria then has a heightened ability to eliminate ROS. As with superoxide
production shown in Figure 13, the ETC stabilizing treatment does not affect NADPH
levels. Another aspect of mitochondrial function is the availability of NAD and NADH. The
NAD/NADH ratio governs metabolic activity and influences antioxidant cofactor
availability. The control NAD/NADH ratio in this model is high compared to that found in
living systems, but it is proportionally smaller than the cytoplasmic ratio as seen in the
same living systems. Increasing SIRT3 made no difference in the NAD/NADH ratio despite
use of NAD as a cofactor. For drug targets aimed to increase antioxidant activity, this is
important as it predicts minimal unanticipated effects on normal mitochondrial activity.
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AMPK

Concentration Sensitivities
0.000
PGC1α

FOXO3
NAD/NADH
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LKB1 SIRT1

0.029
0.587

0.000 0.001
0.001 0.578
0.346 0.003

0.026
0.000
0.016

0.022 0.587
0.481 0.587
0.009 0.000

Flux Sensitivities

NAM to NMN
AMPK activation
NADH oxidation

Table 4: Cytosolic Target SA Upper: Sensitivities of active transcription factor
concentration and NAD/NADH ratio to targets AMPK, LKB1 and SIRT1. Lower:
Sensitivities of reaction fluxes to perturbations in enzyme concentrations.

This predicts that increased SIRT activity may be a way of strengthening mitochondrial
stress response without interfering with normal respiratory activity. Consistent with Figure
15 and Table 4, decreasing metabolic enzymes had a beneficial impact on the NAD/NADH
ratio. Increasing stable ETC leads to a notably higher ratio. This higher ratio favors
activation of antioxidant pathways which can decompose any stress-related increases in
superoxide not handled by the decreased demand and oxidation of the individual
complexes.
The SAs of cytosolic therapy targets highlight important relationships between the
signaling pathways, feedback loops and transcription factor activation. Both AMPK and
LKB1 had a minor impact on PGC1α and FOXO3 activation (Table 4), but were able to
increase the flux of NMN synthesis, an indicator of SIRT1 activity and the AMPK positive
feedback loop. The sensitivity of active FOXO3 to SIRT1 concentrations indicates that
SIRt1 is important for FOXO3 activation. However, there is potential for AMPK treatment
to increase the positive feedback loop with SIRT1 to increase FOXO3 activation. The

Modeling the effects of SC formation and stress response on AD progression

27

15

Figure 15: Changes in mitochondrial NAD/NADH ratios with target treatments.
Metabolic enzyme treatment (blue) made the largest impact on the NAD/NADH
ratio. The stabilized ETC treatment (green) caused the ratio to triple while SIRT3
treatment (purple) did not change the NAD/NADH ratio

correlation between AMPK activity and the NAD/NADH ratio (Table 4) results in the
beneficial increase in SIRT1 activity shown by the increase in nicotinamide (NAM).
The cytosolic reactions shown in this model are only in response to oxidative
stress. They are analyzed for changes in transcription factor activation. PGC1α and
FOXO3 both require SIRT1 deacetylation and AMPK phosphorylation to enter the nucleus.
The activity of these proteins is increased with increasing oxidative stress in vitro (Duan
et al., 2016), but this model shows a preferential activation of FOXO3 (Figure 16). There
was no change in ATP/AMP ratio.
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The model predicted that FOXO3

16

is preferentially activated by oxidative
stress. The lack of PGC1α activation
indicates that it is more sensitive to ATP
availability

and

production

which

deactivates AMPK. SIRT1 is predicted to
be the more effective therapeutic target
due to the changes in the FOXO3a
activation and its widespread impact on
autophagy activation (Figure 16). AMPK
is a second potential target. It plays an
important role in both FOXO3 and PGC1α
activation, but the low PGC1α activation
in this model hints that changes in ATP
availability may be more important for
PGC1α

activation

than

FOXO3.

Depending on the goal of therapy
(eliminate dysfunctional mitochondria or
restore

respiratory

activity)

different

targets should be considered.

Discussion
The MC hypothesis predicts that
Figure 16: Transcription factor activation with
therapy targets SIRT1 (A), LKB1 (B), and
AMPK (C). The model predicts that FOXO3 will
be preferentially activated by changes in ROS
production. AMPK and SIRT1 are the most
effective treatment options.

deficits in respiratory chain efficiency lead
to ROS accumulation as we age and
predisposes individuals to the onset of
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neurodegenerative diseases (Mosconi, 2013). The work of Dr. Castora’s lab complements
this hypothesis, showing that there are changes in respiratory chain gene expression
levels in individuals with AD. Using this information on gene expression, we created two
models investigating the impacts such differences can have in respiratory function and
subsequent stress-related signaling. ROS production increases the activity of SIRT3,
SOD2, Cat, and Gpx to prevent oxidative damage to surrounding tissues and
mitochondrial DNA (Ighodaro & Akinloye, 2017). If this constitutive antioxidant system
cannot reduce ROS, SIRT3 activates a signaling cascade inducing FOXO3 and PGC1α
mediated transcription of antioxidant and autophagic genes (Brenmoehl & Hoeflich, 2013).
Specific transcription factor activation is important for disease onset and well as mitigation.
By activating the correct transcription factor, we can direct activation of beneficial
pathways and prevent the activation of detrimental pathways. This model predicts that
ROS production does not directly affect ATP production, but preferentially activates the
FOXO3 transcription factor. Therefore, a decrease in ATP resulting from lower respiratory
activity better activates AMPK, initiating PGC1α activation and mitochondrial biogenesis.
As FOXO3 transcriptional targets activates autophagy as well as antioxidant proteins, this
avenue of treatment should be considered with caution. Moderate increases in activity will
likely activate the clearance of ROS and dysfunctional mitochondria, but if changes are
too large they can result in a hyperactive autophagy pathway which is more cytotoxic than
neuroprotective. SIRT1 is a viable target as it is predicted to be important for both FOXO3
and PGC1α activation. AMPK would be effective in upregulating PGClα and increasing
mitochondrial biogenesis inducing the feedback loop to SIRT1 activation. Picking AMPKrelated targets may also provide more balance between FOXO3 and PGC1α activation to
prevent conservation of irreversibly dysfunctional mitochondria that put the entire neuron
at risk.
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Respiratory and metabolic targets present a safer therapeutic avenue. By picking
targets that increase stable SC formation, we can decrease ROS production at its root
with fewer risks of aberrant pathway or signaling changes. CICIII formation is the most
important step in reducing CI related ROS production. By covering one of two oxygen
binding sites as well as increasing CI binding partners, CIII subunit UQCRC1 is predicted
to be the most effective subunit target. The model shadowed this prediction as seen in the
increase in CI sequestered within SC’s.
These model predictions about transcription factor activation and SC assembly
may be of importance when understanding the mitochondrial differences between elder
and long-lived individuals. People who live to be older than 75 years have defective
mitochondria with high peroxide concentrations and low ATP levels (Sgarbi et al., 2014).
The results of this model would predict that this unique trait may be due to sequential
changes in gene transcription allowing for mitochondrial fusion (changes in bioenergetics)
before autophagy activation. This sequence could prevent autophagic degradation
because the hyperfusion of mitochondria make them resistant to degradation. It is unclear
how this adaptation relates to AD, but the correlation with lifespan is favorable. Further
work studying the effects of subunit and antioxidant therapies on mitochondrial stress
response in vitro to assess the utility of these treatments is required to confirm these
predictions.
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Appendix
S1: Complete SC model

S1: Model of potential SC assemblies based on Subunit expression. CI is shown in light blue, CIII
in red and CIV in purple. SC CICIII is shown in purple, CIVCIII in orange and Respirasome in white.
The letter and number pairs represent the potential groupings of subunits (CI(blue): B9=NDUFB9,
B4=NDUFB4, A11=NDUFA11 and S1=NDUFS1; CIII(red): FS1=UQCRFS1, Q=UQCRQ, and
C1=UQCRC1; CIV(orange): 7AL=COX7AL, and 7A2=COX7A2). CICIII is differentiated by the
number of stable inter-complex bonds being formed with 3 being the most in 1 the least. The prefix
“s” represents the presence of CI subunit NDUFS1,an essential subunit for respirasome formation.
This models represents all potential combinations.

Modeling the effects of SC formation and stress response on AD progression
S2: SC assembly model ODE system
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S3: SC assembly Kinetic Parameters
re647
k1
k2
re648
kf_re648
kr_re648
re649
kf_re649
kr_re649
re650
kf_re650
kr_re650
re652
kf_re652
kr_re652
re654
kf_re654
kr_re654
re657
kf_re657
kr_re657
re661
kf_re661
kr_re661
re666
kf_re666
kr_re666
re690
kf_re690
kr_re690
re693
kf_re693
kr_re693

µmol/(l*s)
0.5 l/(µmol*s)
0.05 1/s
µmol/(l*s)
0.3 1/(µmol*s)
0.05 1/s
µmol/(l*s)
0.7 1/(µmol*s)
0.05 1/s
µmol/(l*s)
0.7 1/(µmol*s)
0.05 1/s
µmol/(l*s)
0.8 1/(µmol*s)
0.05 1/s
µmol/(l*s)
0.8 1/(µmol*s)
0.05 1/s
µmol/(l*s)
0.9 1/(µmol*s)
0.01 1/s
nan µmol/(l*s)
0.8 1/(µmol*s)
0.05 1/s
nan µmol/(l*s)
0.3 1/(µmol*s)
0.01 1/s
nan µmol/(l*s)
0.3 1/(µmol*s)
0.05 1/s
nan µmol/(l*s)
0.3 1/(µmol*s)
0.05 1/s

42

Modeling the effects of SC formation and stress response on AD progression
S3: Detailed Oxidative Stress Model

S3: Oxidative stress model showing each explicit reaction used to create the
differential equation system.
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S4: Oxidative Stress Model Equations
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S6: Oxidative Stress Model Final Parameter Set and Concentrations
Initial State
Initial Compartment Sizes
default
1l
matrix
6.83e-19 l
inner membrane space
2.28e-19 l
cell
1e-13 l
Initial Species Values
ETC
4.408 µmol/(l)
ATPsyn
26.9466 µmol/(l)
SOD2
53.759 µmol/(l)
NADH{matrix}
12 µmol/(l)
aSOD2
17.9197 µmol/(l)
Cat
15.1617 µmol/(l)
AMP{matrix}
0.0014 µmol/(l)
ATP{matrix}
1390 µmol/(l)
GSSG
0.041 µmol/(l)
GSH
1.2 µmol/(l)
NADP+
19.6 µmol/(l)
NADPH
51 µmol/(l)
GPx
17.4155 µmol/(l)
GR
0.5972 µmol/(l)
LKB1
0.1789 µmol/(l)
aLKB1
0.0596 µmol/(l)
AMPK
0.0533 µmol/(l)
PRPP{matrix}
6.67 µmol/(l)
PPi{matrix}
0 µmol/(l)
NMN{matrix}
0.0589 µmol/(l)
NAD{matrix}
50 µmol/(l)
SIRT3
0.0075 µmol/(l)
NAM{matrix}
0.4809 µmol/(l)
aSIRT3
0.0013 µmol/(l)
aAMPK
0.0178 µmol/(l)
SIRT1
0.0036 µmol/(l)
aFOXO3
0.00099 µmol/(l)
PPi{cell}
0 µmol/(l)
PRPP{cell}
4.9 µmol/(l)
NMN{cell}
0.0589 µmol/(l)
NAMPT
0.4809 µmol/(l)
NMNAT
0.0049 µmol/(l)
NMNAT3
0.0664 µmol/(l)
inhib{matrix}
0.0012 µmol/(l)
NAM{cell}
0.4809 µmol/(l)
NAD{cell}
85 µmol/(l)
ATP{cell}
1390 µmol/(l)
AMP{cell}
0.0014 µmol/(l)
O2'
0 µmol/(l)
H2O2
10.5 µmol/(l)
H+{matrix}
0.0048 µmol/(l)
H+{"inner membrane space"}
0.1 µmol/(l)
H2O
0 µmol/(l)
O2
32 µmol/(l)
NADH{cell}
1.17 µmol/(l)
inhib{cell}
0.0012 µmol/(l)
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e
0 µmol/(l)
IDH2
8.7951 µmol/(l)
aPGC1a
1.1e-05 µmol/(l)
pac_PGC1a
7.7e-05 µmol/(l)
ac_PGC1a
1.65e-05 µmol/(l)
p_ac_FOXO3
0.003 µmol/(l)
ac_FOXO3{cell}
0.0118 µmol/(l)
FOXO3
0.0039 µmol/(l)
aIDH2
2.9317 µmol/(l)
metabolic
1 µmol/(l)
UCP5
1 µmol/(l)
Initial Global Quantities
Proton Grad
20.8333 dimensionless
ATP/AMP {matrix}
992857 dimensionless
NAD/NADH {cyto}
72.6496 dimensionless
NAD/NADH {matrix}
4.16667 dimensionless
Kinetic Parameters
SIRT3 deact
k1
0.0607443 1/min
SIRT3 disinhib
k1
0.031598 1/min
NAD rdxn {matrix}
kcat_re40_s105
9.184 1/min
kmc_re40_s102_s105 1.5072e-06 µmol/l
AMP transport
kf_re46
1e-05 1/min
ATP consump {mtx}
k1
0.125164 1/min
SOD2 deact
k1
0.00271808 1/min
AMPK deact
kf_re21
0.0183318 l/(µmol*min)
FOXO3 dephos
k1
1.24677e-05 1/min
NAM->NMN{mtx}
k1
111.534 l/(µmol*min)
LKB1 deact
k1
0.0338412 1/min
FOXO3 to matrix
kf_re35
0.0278129 1/min
SIRT3 inhib
k1
1e-05 l/(µmol*min)
SIRT1 disinhib
k1
1.09474 1/min
NADH oxdtn {cyto}
k1
0.13173 1/min
ATP export
kf_re47
17.5096 1/min
ATP hydrolysis
k1
0.23558 1/min
SIRT1 inhib
k1
0.0103606 l/(µmol*min)
NAD rdxn {cyto}
k1
0.00513173 1/min
PGC1a acyl
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k1

0.00109024 1/min

PGC1a
k1
FOXO3a deact
k1
H2O2 decomp (Cat)
kcat_re10_s3
kmc_re10_s18_s3
SIRT3 act
kcat_re1_s14
kmc_re1_s5_s14
e capture
kcat_re9_s21
kmc_re9_s17_s21
kmc_re9_s11_s21
kmc_re9_s6_s21
O2 rad formation
k1
NADH ox (ETC)
kcat_re7_s21
kmc_re7_s16_s21
Peroxide formation (SOD2)
kcat_re4_s24
kmc_re4_s14_s24
kmc_re4_s6_s24
kic_re4_s14_s24
NMN->NAD{matrix}
kcat_re27_s51
kmc_re27_s47_s51
H2O2 decomp (Gpx)
kcat_re11_s63
kmc_re11_s18_s63
kmc_re11_s60_s63
kic_re11_s18_s63
GSSG rdxn
kcat_re18_s64
kmc_re18_s59_s64
kmc_re18_s62_s64
kic_re18_s59_s64
AMPK activation
kcat_re20_s70
kmc_re20_s29_s70
kmc_re20_s116_s70
kic_re20_s29_s70
ATP syn
kcat_re14_s83
kmc_re14_s20_s83
kmc_re14_s90_s83
kic_re14_s20_s83
SOD2 act
kcat_re13_s85
kmc_re13_s22_s85
kmc_re13_s4_s85
kic_re13_s22_s85
FOXO3a exp

0.0386717 1/min
0.0195509 1/min
0.001248 1/min
7.36 µmol/l
0.0257019 1/min
0.0153836 µmol/l
1.264e-05 1/min
0.0353064 µmol/l
0.0143592 µmol/l
0.0242807 µmol/l
1e-05 l/(µmol*min)
2.94443 1/min
0.458844 µmol/l
27.456 1/min
0.007 µmol/l
0.004992 µmol/l
0.01 µmol/l
112.176 1/min
87.1298 µmol/l
30.4704 1/min
5 µmol/l
2.88 µmol/l
0.00408 µmol/l
304.261 1/min
37.516 µmol/l
7.6109 µmol/l
0.0117007 µmol/l
2.16999 1/min
14.7446 µmol/l
18.14 µmol/l
7.40837 µmol/l
1e-05 1/min
0.226778 µmol/l
0.0743971 µmol/l
0.110651 µmol/l
1.44757 1/min
1e-05 µmol/l
1e-05 µmol/l
0.0787856 µmol/l
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kcat_re24_s85
kmc_re24_s81_s85
kmc_re24_s4_s85
kic_re24_s81_s85
NADH ox
kcat_re54_s86
kmc_re54_s123_s86
PGC1a phos
kcat_re69_s86
kmc_re69_s133_s86
FOXO3a phos
kcat_re36_s86
kmc_re36_s34_s86
LKB1 act
kcat_re37_s88
kmc_re37_s69_s88
kmc_re37_s114_s88
kic_re37_s69_s88
FOXO3 act
kcat_re13_s85
kic_re13_s22_s85
kmc_re13_s22_s85
kmc_re13_s4_s85
PGC1 deacyl
kcat_re13_s85
kic_re13_s22_s85
kmc_re13_s22_s85
kmc_re13_s4_s85
NAM->NMN{cell}
kcat_re38_s104
kmc_re38_s113_s104
kmc_re38_s101_s104
kic_re38_s113_s104
NMN->NAD{cell}
kcat_re40_s105
kmc_re40_s102_s105
NADP rdxn
kcat_re73_s127
kmc_re73_s61_s127
kmc_re73_s6_s127
kic_re73_s61_s127
IDH2 deact
k1
IDH2 act
kcat_re86_s5
kmc_re86_s127_s5
kmc_re86_s4_s5
kic_re86_s127_s5
H+ leak
k1

3.24781 1/min
1e-05 µmol/l
1e-05 µmol/l
132.145 µmol/l
1213.99 1/min
7.18526 µmol/l
5.43493 1/min
0.00896693 µmol/l
1.07218 1/min
0.0239716 µmol/l
0.269103 1/min
31.4614 µmol/l
205.788 µmol/l
5.27956 µmol/l
159.577 1/min
260.251 µmol/l
117.909 µmol/l
1.95425 µmol/l
0.0220595 1/min
53.1197 µmol/l
183.867 µmol/l
2.67021 µmol/l
21.1889 1/min
41.2056 µmol/l
0.860579 µmol/l
0.00753388 µmol/l
0.655759 1/min
47.1165 µmol/l
1e-05 1/min
12.0712 µmol/l
99.8827 µmol/l
0.01616 µmol/l
0.0444651 1/min
50.985 1/min
1e-05 µmol/l
4.62915 µmol/l
1e-05 µmol/l
0.00026904 1/min
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S7: Initial Oxidative Stress Model Parameter Values
Initial State
Kinetic Parameters
SIRT3 deact
nan µmol/(l*min)
k1
1.8 1/min
SIRT3 disinhib
nan µmol/(l*min)
k1
0.0197 1/min
NAD rdxn {matrix}
nan µmol/(l*min)
kcat_re40_s105
1.04781 1/min
kmc_re40_s102_s105
0.021257 µmol/l
AMP transport
nan µmol/(min)
kf_re46
0.24 1/min
ATP consump {mtx}
nan µmol/(l*min)
k1
0.204 1/min
SOD2 deact
nan µmol/(l*min)
k1
0.03 1/min
AMPK deact
nan µmol/(l*min)
kf_re21
0.039 l/(µmol*min)
FOXO3 dephos
nan µmol/(l*min)
k1
0.0001 1/min
NAM->NMN{mtx}
nan µmol/(l*min)
k1
32 l/(µmol*min)
LKB1 deact
nan µmol/(l*min)
k1
0.03 1/min
FOXO3 to matrix
nan µmol/(min)
kf_re35
0.24 1/min
SIRT3 inhib
nan µmol/(l*min)
k1
0.197 l/(µmol*min)
SIRT1 disinhib
nan µmol/(l*min)
k1
1.79 1/min
NADH oxdtn {cyto}
nan µmol/(l*min)
k1
0.05 1/min
ATP export
nan µmol/(min)
kf_re47
9.6 1/min
ATP hydrolysis
nan µmol/(l*min)
k1
0.204 1/min
SIRT1 inhib
nan µmol/(l*min)
k1
0.01 l/(µmol*min)
NAD rdxn {cyto}
nan µmol/(l*min)
k1
0.01 1/min
PGC1a acyl
nan µmol/(l*min)
k1
0.03 1/min
PGC1a
nan µmol/(l*min)
k1
0.03 1/min
FOXO3a deact
nan µmol/(l*min)
k1
0.03 1/min
H2O2 decomp (Cat)
nan µmol/(l*min)
kcat_re10_s3
0.0012 1/min
kmc_re10_s18_s3
20 µmol/l
SIRT3 act
nan µmol/(l*min)
kcat_re1_s14
0.03 1/min
kmc_re1_s5_s14
0.2 µmol/l
e capture
nan µmol/(l*min)
kcat_re9_s21
10 1/min
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kmc_re9_s17_s21
0.01 µmol/l
kmc_re9_s11_s21
0.01 µmol/l
kmc_re9_s6_s21
0.01 µmol/l
O2 rad formation
nan µmol/(l*min)
k1
0.57 l/(µmol*min)
NADH ox (ETC)
nan µmol/(min)
kcat_re7_s21
1 1/min
kmc_re7_s16_s21
0.01 µmol/l
Peroxide formation (SOD2)
nan µmol/(l*min)
kcat_re4_s24
24 1/min
kmc_re4_s14_s24
0.005 µmol/l
kmc_re4_s6_s24
0.005 µmol/l
kic_re4_s14_s24
0.01 µmol/l
NMN->NAD{matrix}
nan µmol/(l*min)
kcat_re27_s51
150 1/min
kmc_re27_s47_s51
66.2 µmol/l
H2O2 decomp (Gpx)
nan µmol/(l*min)
kcat_re11_s63
31.74 1/min
kmc_re11_s18_s63
5 µmol/l
kmc_re11_s60_s63
2 µmol/l
kic_re11_s18_s63
0.01 µmol/l
GSSG rdxn
nan µmol/(l*min)
kcat_re18_s64
144 1/min
kmc_re18_s59_s64
56.7 µmol/l
kmc_re18_s62_s64
7.9 µmol/l
kic_re18_s59_s64
0.01 µmol/l
AMPK activation
nan µmol/(l*min)
kcat_re20_s70
10 1/min
kmc_re20_s29_s70
67.2 µmol/l
kmc_re20_s116_s70
48 µmol/l
kic_re20_s29_s70
67.2 µmol/l
ATP syn
nan µmol/(min)
kcat_re14_s83
0.5 1/min
kmc_re14_s20_s83
0.1 µmol/l
kmc_re14_s90_s83
0.1 µmol/l
kic_re14_s20_s83
0.01 µmol/l
SOD2 act
nan µmol/(l*min)
kcat_re13_s85
0.197 1/min
kmc_re13_s22_s85
25.5 µmol/l
kmc_re13_s4_s85
140 µmol/l
kic_re13_s22_s85
29.4 µmol/l
FOXO3a exp
nan µmol/(min)
kcat_re24_s85
0.197 1/min
kmc_re24_s81_s85
25.5 µmol/l
kmc_re24_s4_s85
673.3 µmol/l
kic_re24_s81_s85
29.4 µmol/l
NADH ox
nan µmol/(l*min)
kcat_re54_s86
270 1/min
kmc_re54_s123_s86
8 µmol/l
PGC1a phos
nan µmol/(l*min)
kcat_re69_s86
3.42 1/min
kmc_re69_s133_s86
0.0093 µmol/l
FOXO3a phos
nan µmol/(l*min)
kcat_re36_s86
0.72 1/min
kmc_re36_s34_s86
0.26 µmol/l
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LKB1 act
nan µmol/(l*min)
kcat_re37_s88
14.4 1/min
kmc_re37_s69_s88
25.5 µmol/l
kmc_re37_s114_s88
82.6 µmol/l
kic_re37_s69_s88
60.5 µmol/l
FOXO3 act
nan µmol/(l*min)
kcat_re13_s85
14.4 1/min
kic_re13_s22_s85
60.5 µmol/l
kmc_re13_s22_s85
82.6 µmol/l
kmc_re13_s4_s85
25.5 µmol/l
PGC1 deacyl
nan µmol/(l*min)
kcat_re13_s85
14.4 1/min
kic_re13_s22_s85
60.5 µmol/l
kmc_re13_s22_s85
82.6 µmol/l
kmc_re13_s4_s85
25.5 µmol/l
NAM->NMN{cell}
nan µmol/(l*min)
kcat_re38_s104
32 1/min
kmc_re38_s113_s104
22.9 µmol/l
kmc_re38_s101_s104
2.67 µmol/l
kic_re38_s113_s104
0.05 µmol/l
NMN->NAD{cell}
nan µmol/(l*min)
kcat_re40_s105
150 1/min
kmc_re40_s102_s105
66.2 µmol/l
NADP rdxn
nan µmol/(l*min)
kcat_re73_s127
14400 1/min
kmc_re73_s61_s127
7.9 µmol/l
kmc_re73_s6_s127
56.7 µmol/l
kic_re73_s61_s127
0.01 µmol/l
IDH2 deact
nan µmol/(l*min)
k1
0.03 1/min
IDH2 act
nan µmol/(l*min)
kcat_re86_s5
14.4 1/min
kmc_re86_s127_s5
82.6 µmol/l
kmc_re86_s4_s5
25.5 µmol/l
kic_re86_s127_s5
60.5 µmol/l
H+ leak
nan µmol/(l*min)
k1
1e-05 1/min
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